Using riboflavin, UV light in specialized device reduces SARS-CoV-2 pathogens in plasma, whole blood
The research team used existing technologies to treat nine plasma and three whole-blood products.
The research team used existing technologies to treat nine plasma and three whole-blood products.
CSU investigators will run tests for up to 45,000 workers and nursing home residents in the state.
The two teams selected from CSU are among six grant winners from across the state.
As day-to-day interactions have been disrupted by COVID-19, communal howling offers a way to express both joy and grief – and can include coyotes.
Over the last two months, a team at CSU tested samples from 462 healthcare workers in Colorado.
Over the last decade, there have been advances in manufacturing and in strategies to rapidly produce a vaccine.
Propelled by the COVID-19 pandemic, a CSU research team is pursuing a vaccine that would thwart the novel coronavirus using a genetically modified form of the well-known probiotic Lactobacillus acidophilus, a bacterium commonly ingested in yogurt and other foods for gut health.
The core technology for the new disinfectant is based on the same principle CSU disease researchers are testing for a vaccine against the novel coronavirus.
Take a look at recent research highlights from Colorado State University.
In addition to receiving $4,000 for travel and research expenses, the new fellows will also engage in professional development, leadership and mentorship opportunities throughout the academic year.